Opsens to Present Live Via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 9:15am ET

QUEBEC CITY, Sept. 29, 2015 /PRNewswire/ --  Opsens Inc. ("Opsens" or the "Company") (TSXV: OPS) (OTCQX: OPSSF), a company focusing on the measure of Fractional Flow Reserve ("FFR") in interventional cardiology, announced today that Louis Laflamme, President and Chief Executive Officer, will present at VirtualInvestorConferences.com hosted by the OTC Markets Group, on Thursday, October 1, 2015, at 9:15 a.m. ET.

During this presentation, Mr. Laflamme will give a corporate overview, including recent development on the Company.

Individual, institutional investors and advisors may attend this free interactive real-time virtual event by clicking on the following link:  http://tinyurl.com/101pre.

VirtualInvestorConferences.com is a live, interactive online event where investors are invited to ask the company questions in real-time - in the presentation hall as well as in the association's "virtual trade booth". Attendees who are not able to join the event live on the day of the conference may access the on-demand archive available for 90 days. Investors are invited to pre-register to save time and receive event updates.

Opsens aims to become a key player in the guidewire FFR market with the OptoWire, a nitinol-based optical guidewire. The OptoWire provides intra-coronary blood pressure measurements with unique, patented optical pressure guidewire technologies. It is immune to adverse effects related to blood contact, and allows easy and reliable connectivity that leads to reliable FFR measurements in extended conditions of usage. The OptoWire is also designed to provide cardiologists with a guidewire that provides optimal performance to navigate coronary arteries and cross blockages with ease and safety. Based on industry sources, the FFR market represented more than US$300 million in sales in 2014 and is expected to reach US$1 billion in the medium-term. 

About Opsens Inc. (www.opsens.com or www.opsensmedical.com)

Opsens focuses mainly on the measure of Fractional Flow Reserve ("FFR") in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. Opsens is also involved in industrial activities. The Company develops, manufactures and installs innovative fibre optic sensing solutions for critical applications such as the monitoring of oil wells and other demanding industrial applications.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Logo - http://photos.prnewswire.com/prnh/20150928/271487LOGO
Logo - http://photos.prnewswire.com/prnh/20150928/271486LOGO

SOURCE Opsens Inc.

Related Links

http://www.opsens.com